Glioblastoma Multiforme Recorded Session
Glioblastoma Multiforme is an aggressive type of cancer that occurs in the brain or spinal cord and this type of cancer accounts for about 70% of malignant brain tumors. This session will help you understand the background, current therapy and management, tumor progression verses pseudoprogression, and personalized therapy.
If you attended Glioblastoma Multiforme on September 9, 2021, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Target Audience
This course is intended for all physicians including generalists, neurologists, intensivists, radiologists, and pathologists, RN's, PA's, NP's, RTT's, and various other members of the health care team
Learning Objectives
At the end of this session, learners should be able to:
- Recognize the characteristics and prognostic factors of Glioblastoma Multiforme
- Apply current evaluation and treatment plans of Glioblastoma Multiforme
Faculty
Isaac Melguizo-Gavilanes, MD; Advocate Aurora Health
Eric Maas, MD; Advocate Aurora Health
Paul Vilar, Director; Advocate Aurora Health
Rachael Wade, Senior Director; Advocate Aurora Health
Amy Campbell, Executive Assistant; Advocate Aurora Health
Disclosure
The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.
Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Advocate Aurora Health designates this enduring material for a maximum of .50 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 0.50 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 0.50 AttendanceAttendance Credit
- 0.50 Approved AMA PRA Category 1 Credit™
Price
If you attended Glioblastoma Multiforme on September 9, 2021, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Click “Take Course” to register for this program.
Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.